How much cash does Medline, Inc. generate?

Medline, Inc. (MDLN) generated $2.0B in operating cash flow over the trailing twelve months.

What is Medline, Inc. 's free cash flow?

After $371.0M of capital expenditures, Medline, Inc. 's free cash flow was $1.6B over the trailing twelve months, up 13.8% year over year.

Where does Medline, Inc. 's cash flow data come from?

Every line is extracted from Medline, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Medline, Inc. MDLN Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Depreciation and amortization	$254M—	——	——	——	$247M+1.1%
Stock-based compensation	$23M—	——	——	——	$19M+24.6%
Deferred income taxes	$37M—	——	——	——	-$4M+33.3%
Amortization of debt issuance costs	$11M—	——	——	——	$15M+5.3%
Provision for credit losses	$1M—	——	——	——	$26M+65.1%
Change in accounts receivable	$146M—	——	——	——	$98M+53.1%
Change in inventories	$42M—	——	——	——	-$71M-152%
Change in accounts payable	$6M—	——	——	——	$35M+32.1%
Change in accrued liabilities	$72M—	——	——	——	$34M+119%
Change in other assets	$19M—	——	——	——	$28M+343%
Change in other liabilities	-$32M—	——	——	——	-$9M+59.1%
Other working capital changes	-$3M—	——	——	——	-$6M-209%
Loss on extinguishment of debt	——	-$14.5M0.0%	-$14.5M0.0%	-$14.5M0.0%	-$14.5M-81.3%
Net cash from operating activities	$412M—	——	——	——	$682M+54.2%
Capital expenditures	$96M—	——	——	——	$98M+10.7%
Acquisitions, net of cash acquired	$0—	——	——	——	-$6M-102%
Other investing activities	——	$0—	$0—	$0—	$0-100%
Net cash from investing activities	-$96M—	——	——	——	-$92M+75.4%
Repurchases of common stock	$0—	——	——	——	$9M+80.0%
Proceeds from issuance of debt	——	$1.89B0.0%	$1.89B0.0%	$1.89B0.0%	$1.89B-52.5%
Repayments of debt	$0—	——	——	——	$179M+331%
Distributions to noncontrolling interests	$10M—	——	——	——	$0—
Payment of debt issuance costs	——	$0—	$0—	$0—	$0-100%
Net cash from financing activities	-$13M—	——	——	——	-$9M+97.8%
Effect of exchange rate changes on cash	-$7M—	——	——	——	$9M+1,700%
Net increase (decrease) in cash	$296M—	——	——	——	$590M+277%
Interest paid	$61M—	——	——	——	$136M-46.8%
Income taxes paid	——	$15.5M0.0%	$15.5M0.0%	$15.5M0.0%	$15.5M-38.6%
Amortization expense related to capitalized debt issuance costs	$11M—	——	——	——	$15M+5.3%
Amortization of inventory step-up	——	$0—	$0—	$0—	$0-100%
Change in fair value of the conversion option of the convertible senior notes	——	$10.25M0.0%	$10.25M0.0%	$10.25M0.0%	$10.25M—
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax	$12M—	——	——	——	-$29M-1,260%
Increase (Decrease) in Other Operating Assets	$19M—	——	——	——	$28M+343%
Non-cash lease expense	$17M—	——	——	——	$17M+11.5%
Other Noncash Income (Expense)	-$3M—	——	——	——	-$6M-209%
Accounts Receivable, Credit Loss Expense (Reversal)	$1M—	——	——	——	$26M+65.1%
Payments for Asset Acquisitions	——	$8.25M0.0%	$8.25M0.0%	$8.25M0.0%	$8.25M+230%
Payment for (Proceeds from) Other Investing Activity	——	$0—	$0—	$0—	$0-100%
Payments For Purchase of Redemptions of Common Units From Pre-IPO Common Unitholders, Initial Public Offering	——	$492.5M0.0%	$492.5M0.0%	$492.5M0.0%	$492.5M—
Payments Of Debt Issuance Costs	——	$0—	$0—	$0—	$0-100%
Payments Of Stock Issuance Costs	$3M—	——	——	——	$0—
Payments to Noncontrolling Interests	$10M—	——	——	——	$0—
Net proceeds from sales of subsidiary shares	——	$1.76B0.0%	$1.76B0.0%	$1.76B0.0%	$1.76B—
Repayments of Long-Term Lines of Credit	$0—	——	——	——	$179M+331%
Payments Of Capital Distribution	——	$129.5M0.0%	$129.5M0.0%	$129.5M0.0%	$129.5M-65.9%
Proceeds From Issuance Of Other Long Term Debt	——	$1.89B0.0%	$1.89B0.0%	$1.89B0.0%	$1.89B-52.5%
Leased assets obtained in exchange for operating lease liabilities	——	$28.75M0.0%	$28.75M0.0%	$28.75M0.0%	$28.75M-19.6%
Cash received from interest rate hedging activities	$7M—	——	——	——	$15M-64.7%
Income Taxes Paid, Net	——	$15.5M0.0%	$15.5M0.0%	$15.5M0.0%	$15.5M-38.6%
Non-cash capital contribution	——	$0—	$0—	$0—	$0—
Recognition of deferred tax assets from equity transactions	$294M—	——	——	——	$0—
Recognition of tax receivable agreement liability	$479M—	——	——	——	$0—
Free cash flow	$316M—	——	——	——	$584M+65.1%
Free cash flow	$316M—	——	——	——	$584M+65.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Medline, Inc. .

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Medline, Inc. generate?: Medline, Inc. (MDLN) generated $2.0B in operating cash flow over the trailing twelve months.
What is Medline, Inc. 's free cash flow?: After $371.0M of capital expenditures, Medline, Inc. 's free cash flow was $1.6B over the trailing twelve months, up 13.8% year over year.
Where does Medline, Inc. 's cash flow data come from?: Every line is extracted from Medline, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.